X‑Chem transitions executives into new roles, appoints new Chief Executive Officer X‑Chem transitions executives into new roles, appoints new Chief Executive Officer X-Chem, the leading provider of innovative solutions in early-stage drug discovery, today announced executive management team changes aimed at expanding its position as a... 2cureX announces changes to the Board of Directors 2cureX announces changes to the Board of Directors 2cureX, a pioneer in the use of 3D tumoroids for predicting cancer treatment efficacy, is implementing significant changes in its governance resulting in four Board members... Stuart Quin joins GHO Capital as Partner Stuart Quin joins GHO Capital as Partner Former CEO of Medica Group and regional CEO of Synlab to support the continued growth of GHO Capital’s portfolio and origination of future investments SpliceBio appoints leading ophthalmology expert Aniz Girach as Chief Medical Officer SpliceBio appoints leading ophthalmology expert Aniz Girach as Chief Medical Officer Appointment further strengthens SpliceBio’s leadership team as it accelerates lead programme targeting Stargardt disease towards clinical development Sphere Fluidics appoints Dr Graeme Daniels as Vice President of Sales and Marketing Sphere Fluidics appoints Dr Graeme Daniels as Vice President of Sales and Marketing Appointment to senior leadership team strengthens the Company’s plans for continued growth to advance its commercial ambitions Lucas Sauer-Jones appointed as Vice President & General Manager of Veranova’s New England sites Lucas Sauer-Jones appointed as Vice President & General Manager of Veranova’s New England sites Sauer-Jones will be responsible for US API maker Veranova’s sites in Devens and North Andover Industry veteran Abbas Hussain appointed as Chair of Asceneuron Industry veteran Abbas Hussain appointed as Chair of Asceneuron This follows the appointment of Barbara Angehrn Pavik as Chief Executive Officer, signaling a concerted effort to propel the development of groundbreaking treatments aimed at... OM Pharma appoints Roch Ogier as Chief Executive Officer OM Pharma appoints Roch Ogier as Chief Executive Officer OM Pharma, a global biopharmaceutical company headquartered in Switzerland, announced the appointment of Roch Ogier as Chief Executive Officer (CEO), effective January 1, 2024 Camena Bioscience appoints Dr Nicola Thompson as Chair of the Board Camena Bioscience appoints Dr Nicola Thompson as Chair of the Board The appointment supports ambitious commercialisation strategy for DNA synthesis platform, gSynth, and follows $10m Series A financing to scale operations Astraveus appoints Dr Lars Henrik Peeck as Chief Business Development Officer Astraveus appoints Dr Lars Henrik Peeck as Chief Business Development Officer Appointment signifies a pivotal move for Astraveus as it expands its executive team to advance its groundbreaking cell and gene therapy (CGT) manufacturing solutions Rentschler Biopharma SE appoints Gunnar Voss von Dahlen as Chief Financial Officer and completes Executive Board Rentschler Biopharma SE appoints Gunnar Voss von Dahlen as Chief Financial Officer and completes Executive Board Rentschler Biopharma SE, a leading contract development and manufacturing organisation (CDMO) for biopharmaceuticals, including Advanced Therapy Medicinal Products (ATMPs),... Santhera appoints Executive Committee members as it transitions into commercial stage Santhera appoints Executive Committee members as it transitions into commercial stage Santhera Pharmaceuticals (SIX: SANN) announces the promotion of Geert Jan van Daal, MD, PhD, to Chief Commercial Officer (CCO) and of Marc Schrader to Chief Technology Officer... Jose Ibietatorremendia to join Veranova as SVP, General Counsel and Secretary Jose Ibietatorremendia to join Veranova as SVP, General Counsel and Secretary Veranova announces the appointment of Jose Ibietatorremendia as the company’s SVP, General Counsel and Secretary, reporting to Chief Executive Officer, Mike Riley Transgene strengthens its leadership team to accelerate its growth strategy Transgene strengthens its leadership team to accelerate its growth strategy Transgene is pleased to announce the appointment of Arnaud Dubarry as Chief Financial Officer (CFO), effective 1 January 2024 Dr Steven Chatfield, an advisor to the vaccines task force during the COVID pandemic, joins Stablepharma Dr Steven Chatfield, an advisor to the vaccines task force during the COVID pandemic, joins Stablepharma Stablepharma is delighted to announce that Dr Steven Chatfield, an internationally recognised expert in the field of vaccines and infectious disease, has joined the advisory board Versameb names Dr Alexandre LeBeaut as Chair of the Board of Directors Versameb names Dr Alexandre LeBeaut as Chair of the Board of Directors Versameb AG, a preclinical stage company focused on transforming RNA therapeutics to treat unmet medical needs, announces that its Board of Directors has unanimously appointed...